| Role |
Name |
Disclosure |
Details |
| Author | Zonera Ashraf Ali, MD, Consulting Staff, Main Line Oncology Hematology Associates, Lankenau Cancer Center | Nothing to disclose | Details | | Coauthor | Klaus Radebold, MD, PhD, Research Associate, Department of Surgery, Yale University School of Medicine | Nothing to disclose | Details | | Medical Editor | Pradyumma D Phatak, MD, Chair, Associate Professor, Department of Internal Medicine, Division of Hematology and Medical Oncology, Rochester General Hospital | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | CME Editor | Rajalaxmi McKenna, MD, FACP, Consulting Staff, Department of Medicine, Southwest Medical Consultants, SC, Good Samaritan Hospital, Advocate Health Systems | Nothing to disclose | Details | | Chief Editor | John S Macdonald, MD, Professor of Medicine, New York Medical College; Chief, Division of Medical Oncology, St Vincent's Hospital and Medical Center; Medical Director, Saint Vincent's Comprehensive Cancer Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Zonera Ashraf Ali, Author |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Klaus Radebold, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Rajalaxmi McKenna, CME Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| John S Macdonald, Chief Editor |
The contributor discloses no conflict of interest. |
|